B

Blue Jet Healthcare Ltd
NSE:BLUEJET

Watchlist Manager
Blue Jet Healthcare Ltd
NSE:BLUEJET
Watchlist
Price: 554.05 INR 2.98% Market Closed
Market Cap: 96.1B INR

Blue Jet Healthcare Ltd
Pre-Tax Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Blue Jet Healthcare Ltd
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
B
Blue Jet Healthcare Ltd
NSE:BLUEJET
Pre-Tax Income
₹4.1B
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Pre-Tax Income
₹75.3B
CAGR 3-Years
20%
CAGR 5-Years
30%
CAGR 10-Years
15%
Cipla Ltd
NSE:CIPLA
Pre-Tax Income
₹70.4B
CAGR 3-Years
25%
CAGR 5-Years
22%
CAGR 10-Years
12%
Divi's Laboratories Ltd
NSE:DIVISLAB
Pre-Tax Income
₹32.4B
CAGR 3-Years
-3%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Lupin Ltd
NSE:LUPIN
Pre-Tax Income
₹53.9B
CAGR 3-Years
164%
CAGR 5-Years
39%
CAGR 10-Years
6%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Pre-Tax Income
₹28.8B
CAGR 3-Years
32%
CAGR 5-Years
16%
CAGR 10-Years
4%
No Stocks Found

Blue Jet Healthcare Ltd
Glance View

Market Cap
96.1B INR
Industry
N/A

Blue Jet Healthcare Ltd is a IN-based company operating in industry. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2023-11-01. Blue Jet Healthcare Limited is an India-based specialty pharmaceutical and healthcare ingredients and intermediates company. The Company’s operations are primarily organized in three product categories: contrast media intermediates, high-intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs). Contrast media are agents used in medical imaging to enhance the visibility of body tissues under X-rays, computed tomography (CT), magnetic resonance imaging (MRI) or ultrasound. Its high-intensity sweetener business includes development, manufacturing and marketing of saccharin and its salts. The Company’s contract development and manufacturing organization (CDMO) activity in the pharma intermediate and API business is primarily focused on collaborating with innovator pharmaceutical companies and multi-national generic pharmaceutical companies by providing them with pharma intermediates that serve as building blocks for APIs in chronic therapeutic areas.

BLUEJET Intrinsic Value
472.04 INR
Overvaluation 15%
Intrinsic Value
Price
B

See Also

What is Blue Jet Healthcare Ltd's Pre-Tax Income?
Pre-Tax Income
4.1B INR

Based on the financial report for Mar 31, 2025, Blue Jet Healthcare Ltd's Pre-Tax Income amounts to 4.1B INR.

What is Blue Jet Healthcare Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 3Y
19%

Over the last year, the Pre-Tax Income growth was 85%. The average annual Pre-Tax Income growth rates for Blue Jet Healthcare Ltd have been 19% over the past three years .

Back to Top